Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood and subsequently develop type 1 diabetes before adulthood. Primary prevention of type 1 diabetes will require early intervention in genetically at-risk infants. The objective of this study was to determine to what extent genetic scores (two previous genetic scores and a merged genetic score) can improve the prediction of type 1 diabetes.This article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site
OBJECTIVEWe tested the ability of a type 1 diabetes (T1D) genetic risk score (GRS) to predict progre...
This is the author accepted manuscript. The final version is available from American Diabetes Associ...
Background: Progression time from islet autoimmunity to clinical type 1 diabetes is highly variable ...
Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood and subseque...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
Background: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...
Background: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...
<div><p>Background</p><p>Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells ...
BACKGROUND: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
This is the final version of the article. Available from Public Library of Science via the DOI in th...
OBJECTIVE: We tested the ability of a type 1 diabetes (T1D) genetic risk score (GRS) to predict prog...
This is the author accepted manuscript. The final version is available from Nature Research via the ...
OBJECTIVEWe tested the ability of a type 1 diabetes (T1D) genetic risk score (GRS) to predict progre...
This is the author accepted manuscript. The final version is available from American Diabetes Associ...
Background: Progression time from islet autoimmunity to clinical type 1 diabetes is highly variable ...
Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood and subseque...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
Background: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...
Background: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...
<div><p>Background</p><p>Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells ...
BACKGROUND: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
This is the final version of the article. Available from Public Library of Science via the DOI in th...
OBJECTIVE: We tested the ability of a type 1 diabetes (T1D) genetic risk score (GRS) to predict prog...
This is the author accepted manuscript. The final version is available from Nature Research via the ...
OBJECTIVEWe tested the ability of a type 1 diabetes (T1D) genetic risk score (GRS) to predict progre...
This is the author accepted manuscript. The final version is available from American Diabetes Associ...
Background: Progression time from islet autoimmunity to clinical type 1 diabetes is highly variable ...